Comac Medical is proud to attend the 23rd Orphan Drugs Congress 2025 Europe, taking place April 19–20 2025, at the Copthorne Tara Hotel Kensington, London, United Kingdom. This premier event brings together over 2,000 attendees, including pharmaceutical leaders, biotech innovators, regulatory experts, and patient advocates, all committed to advancing treatments for rare diseases.

Expanding Our Rare Diseases Portfolio

With a strong track record in clinical research, Comac Medical is dedicated to expanding our rare diseases and orphan drugs portfolio. Our Business Development Director, Thomas Dent, is eager to engage in high-impact discussions, explore new collaborations, and contribute to the development of innovative therapies that address unmet medical needs.

The congress will feature in-depth sessions on regulatory advancements, clinical trial strategies, market access, and gene therapies, providing valuable insights into the evolving landscape of orphan drug development.

We look forward to connecting with key stakeholders and shaping the future of rare disease therapeutics.

Get in touch and book a meeting with Thomas Dent today!